Pharmaceutical track and trace systems sales will expand through 2036, with 2D barcodes holding a 47.6% share in 2026 as the leading technology used segment. The market was valued at USD 6.20 billion in 2025 and is expected to reach USD 23.55 billion by 2036, creating an incremental opportunity of USD 16.55 billion.